Characterization of EGFR and ErbB2 expression in atopic dermatitis patients (Q39354993)

11 September 2017

title

Characterization of EGFR and ErbB2 expression in atopic dermatitis patients (English)

1 reference

11 September 2017

1 reference

1

Annika Sääf

0 references

Maria Bradley

object named as

Maria Bradley

8

0 references

Andor Pivarcsi

object named as

Andor Pivarcsi

2

0 references

Magnus Nordenskjöld

object named as

Magnus Nordenskjöld

6

0 references

author name string

Annika Sääf

1

1 reference

11 September 2017

Mårten C G Winge

3

1 reference

11 September 2017

Carl-Fredrik Wahlgren

4

1 reference

11 September 2017

Bernhard Homey

5

1 reference

11 September 2017

Maria Tengvall-Linder

7

1 reference

11 September 2017

publication date

3 May 2012

1 reference

Archives of Dermatological Research

11 September 2017

published in

1 reference

11 September 2017

volume

304

1 reference

11 September 2017

issue

10

1 reference

11 September 2017

page(s)

773-780

1 reference

Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

Epidermal growth factor receptor inhibitor-related skin toxicity: mechanisms, treatment, and its potential role as a predictive marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

Modulation of epidermal growth factor receptor gene transcription by a polymorphic dinucleotide repeat in intron 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

EGFR intron 1 dinucleotide repeat polymorphism is associated with the occurrence of skin rash with gefitinib treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

Polymorphisms of EGFR predict clinical outcome in advanced non-small-cell lung cancer patients treated with Gefitinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

EGFR regulates the expression of keratinocyte-derived granulocyte/macrophage colony-stimulating factor in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

Comparison of Epidermal Growth Factor Binding and Receptor Distribution in Normal Human Epidermis and Epidermal Appendages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

The epidermal growth factor receptor system in skin repair and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

Serum factors regulate the expression of the proliferation-related genes alpha5 integrin and keratin 1, but not keratin 10, in HaCaT keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

Common side effects of anti-EGFR therapy: acneform rash

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

Global expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. III. Independent hospital validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00403-012-1242-4

10.1007/S00403-012-1242-4

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference